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Reply
We are naturally delighted that our recent article has been of
interest both to discussants at the original presentation of the paper
and now among readers of Journal of Vascular Surgery. I am
pleased to respond to the questions posed by Drs Bush and Smith
and Frawley.
There is a large literature in virtually all of the approaches to
cerebral monitoring and cerebral protection during CEA, includ-
ing the articles cited in Drs Bush and Smith’s letter. We had cited
the article by Coyle et al.1 The article by Chaikof et al2 was
reviewed but not cited as part of an effort to keep the number of
citations reasonable. I suspect some readers will think that the 80
citations retained are “too many.” The articles by Illig et al3 and
Sternbach et al4 were published after our article was presented and
accepted for publication, but I believe most of the points raised are
addressed in our article and postpresentation discussion.
We recognize that much of the recent literature discusses CEA
with regional anesthesia. However, very little of this literature
makes any effort to compare outcomes using different anesthetic
approaches in contemporaneous patients from the same institution
and none to my knowledge is randomized. We do not advocate
general anesthesia and routine EEG as the only way to manage the
carotid endarterectomy operation. On the contrary, we could not
agree more with Dr Bush and Smith’s final paragraph, and as we
state in the final sentence of our article, this approach should be
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considered. Dr Bush cites results from the article by Coyle et al1
that observed no stroke or mortality among patients with con-
tralateral occlusion excluding those who underwent concomitant
coronary surgery. These excellent outcomes are comparable with
our experience as detailed in our article. Although the neurologic
status of an awake patient is certainly a good method of assessing
cerebral perfusion, I believe it is a leap to state “Local anesthesia-
. . . provides the most accurate method . . . .” Even if one accepts
that the neurologic status of an awake patient is the most sensitive
indicator of cerebral perfusion at the time of carotid clamping, an
alternative, and in our view at least as important question, is what
method is most sensitive when the endpoint of interest is whether
the patient emerges from anesthesia with a new neurologic deficit?
As stated in our article, we chose EEG because the prior literature
suggested EEG was nearly if not 100% sensitive using this standard,
albeit at the price of less than perfect specificity, an impression
corroborated by our observations. I would ask Drs Bush and Smith
how they know from their own experience that “Local anesthesi-
a . . . [is] . . . the most accurate method of monitoring the neuro-
logical status of the patient” if, as they state four sentences earlier,
“Shunts are routinely used . . . ”? Dr Bush and Smith state that
they observed no complications related to shunt placement, but
the literature, including some of the articles we cited in the first
paragraph of the Discussion, clearly documents that this is not a
universal experience. We state in the article that our current rate of
selective shunting seems to provide an adequate familiarity, or
using Dr Bush and Smith’s terminology, allows us to “ . . . main-
tain adequate skills . . . ,” so that shunt placement is not unfamiliar
when a shunt needs to be placed quickly.
With respect to the idea that local anesthesia is cerebroprotec-
tive, we would acknowledge that this is one possible conclusion
suggested by Illig et al’s3 observation of a substantially lower
overall rate of EEG changes in patients with regional anesthesia.
This would seem at odds with the prior view that general anesthesia
is cerebroprotective when compared with regional anesthesia, and
there is at least one alternative explanation. All the difference
between local and general anesthesia in Illig et al’s3 paper appeared
to be due to global EEG changes in patients with general anesthe-
sia, an observation not made in their patients with regional anes-
thesia. Global EEG changes may represent a general effect of the
anesthetic agent used and may not indicate cerebral ischemia. Our
approach requires a specific general anesthetic technique and is not
appropriate if the anesthetic is given as in Illig et al’s3 work
“ . . . according to the anesthesiologist’s preference . . . ” since the
EEG may be uninterpretable with some anesthetic agents. Indeed,
Illig et al3 acknowledges the use of nitrous oxide in general
anesthesia patients, an agent known to cause alterations in the EEG
and, therefore, among the anesthetic agents avoided in our practice
as stated on page 1115 of our article in Methods. Were the changes
observed by Illig et al3 present before clamping or did they occur
only after clamping? The former would suggest an explanation
other than ischemia. Furthermore, the observed rate of EEG
change in awake patients (7.4%) in Illig et al’s3 patients seems
unusually low and may represent a sample size problem. For
example, Dr Stoughton et al5 appear to have observed EEG
changes in 6.7%  12.4% or approximately 19% of their awake
patients, remarkably similar to our own (18%) and Illig et al’s3
(15%) observations in patients with general anesthesia. With re-
spect to the use of the intensive care unit, we currently send fewer
than 15% of our post–carotid endarterectomy patients to the
intensive care unit and the remainder are sent to a standard surgical
floor. Furthermore, we have reduced the direct costs associated
with carotid endarterectomy by 53% at our hospital over the last 6
years despite the fact that we continue to employ routine EEG.
With respect to costs, also the subject of most interest to two
of the four discussants after presentation of the paper, Dr Bush and
Smith state “ . . . at Emory University Hospital the EEG charges
run close to $700 . . . .” We have made it clear in the article and
subsequent discussion that we are discussing costs, not charges. In
fact, as stated in the postpresentation discussion, our hospital
charges something on the order of $1700 for this service, so
perhaps it is Emory University that is “ . . . on the low side . . . .”
Our estimate includes total costs, not just technical costs. The costs
we cite are very rough estimates since our hospital, like many
others, has a very hard time providing indirect cost estimates for
some component services, but it was very reassuring to hear that Dr
Mackey’s hospital estimated a cost of $355 for this service, similar
to our own estimate. I would also respectfully offer that there is no
reason to believe “ . . . the time involved . . . must far outweigh
the short time needed . . . .” On the contrary, as discussed in the
postpresentation discussion, we suspect that the increased time to
do the operation in the presence of the shunt, the lower level of
satisfaction with the visualization and completion of the distal
endpoint, and the costs of shunt-related complications may out-
weigh the costs associated with EEG.
We applaud Dr Frawley’s excellent results with high-dose
barbiturate cerebral protection. He and his associates have
achieved these excellent results in a large sample (1000 cases at the
time of their year 2000 publication). We think their results warrant
a prospective controlled trial by other groups to try to confirm their
results. I would be reluctant to employ this technique outside of
such a trial until these excellent results have been duplicated by
others.
We, too, would welcome a randomized trial comparing high-
dose barbiturates with shunting, but I am surprised that Dr Fraw-
ley states in the same sentence that he feels ethically prevented from
conducting such a trial. Who better to test this in a prospective
randomized trial? As he correctly points out, results of CEA have
improved “ . . . around the world . . . ” and this appears to be the
case with multiple approaches to cerebral monitoring and cerebral
protection. I would offer that had he continued with selective
shunting, Dr Frawley’s results with that approach might have
improved along with those of the rest of the world and might not
be distinguishable from his current results with high-dose barbitu-
rates. I wonder whether the prolonged postoperative period of
sedation due to the high-dose barbiturate increases utilization of
other resources such as recovery room time, intensive care unit
stays, ventilators, etc, and any randomized prospective trial should
address these questions in addition to those of neurologic morbid-
ity and mortality. If resource utilization is not increased, then our
concerns about increased time and less satisfactory exposure of the
endarterectomy endpoint would be obviated by routine use of
high-dose barbiturates with no shunts with no apparent increase
(or perhaps even a decrease) in total costs.
Once again, we are pleased that our work has stimulated so
much discussion.
Joseph R. Schneider, MD, PhD
ENH Medical Group and Northwestern
University Medical School
Evanston and Chicago, Ill
REFERENCES
1. Coyle KA, Smith RB III, Salam A, Dodson T, Chaikof E, Lumsden A.
Carotid endarterectomy in patients with contralateral carotid occlusion:
review of a 10-year experience. Cardiovasc Surg 1996;4:71-5.
2. Chaikof E, Dodson T, Thomas B, Smith RB III. Four steps to local
anesthesia for endarterectomy of the carotid artery. Surg Gynecol
Obstet 1993;177:308-10.
3. Illig KA, Sternbach Y, Zhang R, Burchfiel J, Shortell CK, Rhodes JM, et
al. EEG changes during awake CEA. Ann Vasc Surg 2002;16:6-11.
4. Sternbach Y, Illig KA, Zhang R, Shortell CK, Rhodes JM, Davies MG,
et al. Hemodynamic benefits of regional anesthesia for carotid endar-
terectomy. J Vasc Surg 2002;35:333-9.
5. Stoughton J, Nath RL, Abbott WM. Comparison of simultaneous
electroencephalographic and mental status monitoring during carotid
endarterectomy with regional anesthesia. J Vasc Surg 1998;28:1014-
23.
doi:10.1067/mva.2003.14
JOURNAL OF VASCULAR SURGERY
Volume 37, Number 1 Letters to the Editor 241
